(Q45359242)

13 December 2017

title

Mirtazapine and mefloquine therapy for progressive multifocal leukoencephalopathy in a patient infected with human immunodeficiency virus (English)

1 reference

progressive multifocal leukoencephalopathy

13 December 2017

main subject

0 references

1 reference

1 reference

Ryan P Moenster

1

1 reference

13 December 2017

R Andrew Jett

series ordinal

2

1 reference

13 December 2017

publication date

1 March 2012

1 reference

American Journal of Health-System Pharmacy

13 December 2017

published in

1 reference

13 December 2017

volume

69

1 reference

13 December 2017

issue

6

1 reference

13 December 2017

page(s)

496-498

1 reference

Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis

13 December 2017

cites work

1 reference

https://api.crossref.org/works/10.2146%2FAJHP110392

Progressive multifocal leukoencephalopathy and other forms of JC virus disease

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP110392

Mirtazapine in progressive multifocal leukoencephalopathy associated with polycythemia vera

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP110392

Mirtazapine use in human immunodeficiency virus-infected patients with progressive multifocal leukoencephalopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP110392

The human polyomavirus, JCV, uses serotonin receptors to infect cells

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP110392

The atypical antipsychotic agents ziprasidone [correction of zisprasidone], risperdone and olanzapine as treatment for and prophylaxis against progressive multifocal leukoencephalopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP110392

Identification and characterization of mefloquine efficacy against JC virus in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP110392

Mefloquine treatment in a patient suffering from progressive multifocal leukoencephalopathy after umbilical cord blood transplant

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP110392

Successful management of natalizumab-associated progressive multifocal leukoencephalopathy and immune reconstitution syndrome in a patient with multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP110392

Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP110392

Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP110392

31 March 2020

Identifiers

DOI

10.2146/AJHP110392

1 reference

13 December 2017

1 reference